Key points are not available for this paper at this time.
This JAMA Forum discusses 3 regulatory lessons from the US Food and Drug Administration that could be used for regulating new medical devices and technologies, such as those that include artificial intelligence.
Scott Gottlieb (Thu,) studied this question.